CAS NO: | 2042347-69-1 |
生物活性 | AZD9898 is an orally activeleukotriene-C4 synthetase (LTC4S, glutathione S-transferase II)inhibitor, with anIC50of 0.28 nM. AZD9898 mitigates the GABA binding and hepatic toxicity signal. AZD9898 has the potential to treat asthma[1]. | ||||||||||||||||
IC50& Target | IC50: 0.28 nM (LTC4S)[1]. | ||||||||||||||||
体内研究 (In Vivo) | AZD9898 with the single dose of 100 mg/kg is well tolerated and no safety concerns are raised[1].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 457.83 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C20H19ClF3N3O4 | ||||||||||||||||
CAS 号 | 2042347-69-1 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 250 mg/mL(546.05 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |